Higher subfoveal choroidal thickness in choroidal melanomas than in choroidal nevi.


Journal

Retina (Philadelphia, Pa.)
ISSN: 1539-2864
Titre abrégé: Retina
Pays: United States
ID NLM: 8309919

Informations de publication

Date de publication:
22 Aug 2024
Historique:
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 22 8 2024
Statut: aheadofprint

Résumé

To compare subfoveal choroidal thickness (SFCT) between eyes with choroidal melanoma and choroidal nevi. Retrospective study of 126 consecutive patients in a tertiary ocular oncology center. Eyes with tumors located less than two disc-diameters from the fovea were excluded. In eyes with naevi, factors of potential transformation into melanoma were recorded (orange pigment, subretinal fluid, thickness >2 mm, diameter >5 mm, ultrasound hollowness). SFCT was assessed by 3 independent observers on horizontal spectral-domain OCT scans. Sixty-seven eyes with choroidal melanoma and 59 eyes with choroidal nevi were included. The melanoma and nevi groups did not differ in gender (P=0.14) nor age (P=0.34). There was a very good agreement between the three independent observers for SFCT measurements (intraclass correlation coefficient=0.89). Mean SFCT was higher in melanomas (294.3±89.9 µm) than naevi (260.3±76.7 µm) (P=0.013), and the difference remained significant between melanomas and 28 naevi with ≥2 growth risk factors (256.3±77.0 µm) (P=0.027). In a multivariate model, the significant contributors to SFCT were presence of melanoma (P=0.004), younger age (P<0.0001) and shorter lesion distance to the fovea (P=0.016). SFCT may reflect the interplay between melanocytic tumors and their choroidal microenvironment. Its clinical utility should be explored in future studies.

Identifiants

pubmed: 39173172
doi: 10.1097/IAE.0000000000004254
pii: 00006982-990000000-00785
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Abdelmajid Benlarbi (A)

Department of Ocular Oncology, Institut Curie, Paris, France.

Denis Malaise (D)

Department of Ocular Oncology, Institut Curie, Paris, France.
Laboratoire d'Investigations Précliniques, Institut Curie, Paris, France.

Juliana Estrada Walker (JE)

Department of Ocular Oncology, Institut Curie, Paris, France.

François Apéré (F)

Department of Ocular Oncology, Institut Curie, Paris, France.

Livia Lumbroso-Le Rouic (L)

Department of Ocular Oncology, Institut Curie, Paris, France.

Francine Behar-Cohen (F)

Université Paris Cité, Faculté de Médecine, Paris, France.
Centre de Recherche des Cordeliers, INSERM UMR1138 "From physiopathology of ocular diseases to clinical developments", Centre de Recherche des Cordeliers, Paris, France.
Assistance Publique-Hôpitaux de Paris, Department of Ophthalmology, Ophtalmopôle, Hôpital Cochin, Paris, France.

Nathalie Cassoux (N)

Department of Ocular Oncology, Institut Curie, Paris, France.
Université Paris Cité, Faculté de Médecine, Paris, France.
Centre de Recherche des Cordeliers, INSERM UMR1138 "From physiopathology of ocular diseases to clinical developments", Centre de Recherche des Cordeliers, Paris, France.

Alexandre Matet (A)

Department of Ocular Oncology, Institut Curie, Paris, France.
Université Paris Cité, Faculté de Médecine, Paris, France.
Centre de Recherche des Cordeliers, INSERM UMR1138 "From physiopathology of ocular diseases to clinical developments", Centre de Recherche des Cordeliers, Paris, France.

Classifications MeSH